AU2021103389A4 - A Skincare Serum - Google Patents

A Skincare Serum Download PDF

Info

Publication number
AU2021103389A4
AU2021103389A4 AU2021103389A AU2021103389A AU2021103389A4 AU 2021103389 A4 AU2021103389 A4 AU 2021103389A4 AU 2021103389 A AU2021103389 A AU 2021103389A AU 2021103389 A AU2021103389 A AU 2021103389A AU 2021103389 A4 AU2021103389 A4 AU 2021103389A4
Authority
AU
Australia
Prior art keywords
composition
extract
topical skincare
composition further
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021103389A
Inventor
Shaza Skaf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shawelle Pty Ltd
Original Assignee
Shawelle Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2020902044A external-priority patent/AU2020902044A0/en
Application filed by Shawelle Pty Ltd filed Critical Shawelle Pty Ltd
Application granted granted Critical
Publication of AU2021103389A4 publication Critical patent/AU2021103389A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A topical skincare composition comprising the Terminalia Ferdinandiana extract, Saccharide Isomerate and Aloe Barbadensis leaf juice.

Description

A SKINCARE SERUM TECHNICAL FIELD
[0001] The present invention relates to the cosmetics industry and, more particularly to a skin serum composition for improving the quality of skin.
BACKGROUND
[0002] Serums are highly concentrated cosmetic products. Serums tend to give a quicker cosmetic effect than creams. This provides more psychological satisfaction as the results can be seen more quickly. However, it is possible to overdose on certain ingredients in serums. Many currently available serums can have an effect on the skin in the short term, but irritate the skin in the long term. For example, some serums can provide deep penetration moisturisation, but can leave the user with a burning sensation and ultimately lead to skin breakouts, such as pimples or inflammatory skin reactions. Finding the optimum concentration and combination of ingredients is difficult.
[0003] In certain combinations, two ingredients can have a far higher effect than could be expected from their individual activities, thus displaying synergism. One example of such a combination is AmoxicillinTM and ClavulanateTM. Alone, ClavulanateTM has little anti-bacterial activity, but in combination with AmoxicillinT M , it shows highly synergistic activity (refer to Goodman and Gilman's The Pharmacological Basis of Therapeutics, A. G. Gilman et al., eds., Pergamon Press, Inc., 1990, p. 1093). The advantage of such synergism is that the effectiveness of the serum is greatly increased, without a concomitant increase in the dosage level of any one ingredient or the necessary rate of administration. It allows lower quantities of each substance to be administered in combination yet still achieve the desired therapeutic effect. This is particularly important in the treatment of delicate or sensitive tissues, such as the skin, where the ability to reduce the concentration of any one individual ingredient is important.
[0004] The object of the present invention is to provide a skin care serum with an optimum balance and concentration of active ingredients to achieve an almost immediate improvement in skin luminosity and elasticity without irritating the skin.
SUMMARY OF THE INVENTION
[0005] According to the present invention, there is provided a topical skincare composition comprising:
(a) Terminalia Ferdinandiana extract; (b) Saccharide Isomerate; and (c) a carrier.
[0006] Preferably, the carrier is Aloe Barbadensis leaf juice, because it is a natural ingredient that is readily absorbed by the skin. The Aloe Barbadensis leaf juice may be mixed with water in a ratio of 1:100. Aloe Barbadensis leaf juice is able to carry the active ingredients of Terminalia Ferdinandiana and Saccharide Isomerate into the skin.
[0007] Terminalia Ferdinandiana is reputed to be the world's most concentrated whole-food source of vitamin C. It is rich in antioxidants to provide immune support and it protects the skin from free radical damage caused by exposure to ultra-violet radiation.
[0008] Saccharide Isomerate is an excellent moisturising agent, which provides effects for up to 72 hours and can improve skin condition within two weeks. Preferably, the percentage of Saccharide Isomerate is 10%, which the inventor has found through experiment to be the optimum level of this ingredient to maintain skin luminosity and elasticity for a satisfying period of time.
[0009] Additional ingredients of secondary importance in the skincare composition of the present invention may include:
(a) Panthenol, which is the pro-vitamin of D-Pantothenic acid (Vitamin B5) and provides deep penetrating moisture to the skin, stimulating epithelisation to provide wound healing and anti-inflammatory effects; (b) A combination of water, Disodium phosphate, Acetyl hexapeptide-8, Sodium phosphate, Capryloyl glycol; (c) A combination of water, Propanediol, Tephrosia purpurea extract which has soothing properties to main skin elasticity and brightness; and (d) A vanilla and almond like parfum that also preserves cosmetic compositions, provides good product stability and resists microbial contamination.
[0010] Additional ingredients of tertiary importance in the skincare composition of the present invention may include:
(a) Xanthan gum, which is a binder, emulsion stabilizer, surfactant-emulsifying agent, and a viscosity increasing agent. (b) Propanediol, a skin penetration enhancer commonly sold under the trade mark.
-Y
(c) Brachychiton acerifolius extract, which is an advanced natural anti-aging, skin brightening, hydration and hair treatment and helps to intensify the effects of Vitamin C. (d) Hibiscus Sabdariffa extract, which has strong antioxidant and anti-inflammatory properties. It is useful for reducing wrinkles and treating acne. It has been used in skin whitening applications. It can repair and reverse skin damage. (e) Tasmannia Lanceolata leaf extract, which has the highest oxygen radical absorbance capacity (antioxidant) rating currently achieved and helps to prevent the strengthens capillaries. (e) Tasmannia Lanceolata berry extract delivers powerful antioxidants, anti-inflammatory, anti-acne and skin conditioning properties. It also supports Vitamin C and collagen production. (f) Calitris Glaucophylla leaf extract, which has anti-inflammatory agents, anti-aging effects and skin toning properties. (g) Davidsonia Jerseyana extract, which has a potent anti-inflammatory and antioxidant content that improves the appearance of fine lines and wrinkles, promotes skin elasticity through enhanced collagen and elastin production. (h) Arnica Montana flower extract, which contains compounds that anti-aging, whitening, acne, repair and reverse skin damage. (i) Kunzea Pomifera extract, which has high levels of antioxidants. (j)Anigozanthos Flavidus flower extract, which is used for skin repair, hydration, anti ageing and has cooling effect on the skin. (k) Narcissus Tazetta extract which has soothing properties to main skin elasticity and brightness. (1) Schisandra Chinensis fruit extract is a fruit extract that has been clinically proven improve skin resilience and firmness. (m)Magnolia Grandiflora oil which is used as a fragrance and also has soothing effects for the skin.
DETAILED DESCRIPTION
[0011] The ingredients of the present invention can be mixed at room temperature. The first step in the mixing process is to reconstitute the Aloe Barbadensis leaf juice powder with distilled water. Preferably, the organic Aloe Barbadensis leaf juice powder is mixed in the ratio of 1:100 with water. The Aloe Barbadensis leaf juice and water mixture acts as a carrier for the other ingredients listed below. The ingredients should be added in the following phases:
-T
%w/w Ingredient Number
63.8 Aloe Barbadensis leaf juice A 0.5 Xanthan gum A 10 Saccharide Isomerate B 5 Panthenol B 1 Fragrance/parfum B A combination of water, 2 Disodium Phosphate, Acetyl C Hexapeptide-8, Sodium Phosphate, Capryloyl Glycol A combination of water, 2 propanediol and Tephrosia C Purpurea seed extract 0.5 Propanediol C 10 Terminalia Ferdinandiana D extract 0.5 Brachychiton acerifolius D extract 0.5 Hibiscus Sabdariffa flower D extract 0.5 Tasmannia Lanceolata leaf D extract 0.5 Tasmannia Lanceolata berry D extract 0.5 Calitris Glaucophylla leaf D extract 0.5 Davidsonia Jerseyana plum D extract 0.5 Arnica Montana flower extract D 0.5 Kunzea Pomifera extract D 0.5 Anigozanthos Flavidus extract D
0.1 Schisandra Chinensis fruit D extract 0.5 Narcissus Tazetta bulb extract D 0.1 Magnolia Grandiflora oil E
Concluding Remarks
[0012] In the present specification and claims (if any), the word 'comprising' and its derivatives including 'comprises' and 'comprise' include each of the stated integers but does not exclude the inclusion of one or more further integers.
[0013] Reference throughout this specification to 'one embodiment' or 'an embodiment' means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, the appearance of the phrases 'in one embodiment' or 'in an embodiment' in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more combinations.
[0014] In compliance with the statute, the invention has been described in language more or less specific to structural or methodical features. It isto be understood that the invention is not limited to specific features shown or described since the means herein described comprises preferred forms of putting the invention into effect. The invention is, therefore, claimed in any of its forms or modifications within the proper scope of the appended claims (if any) appropriately interpreted by those skilled in the art.

Claims (20)

1. A topical skincare composition comprising:
(a) Terminalia Ferdinandiana extract; (b) Saccharide Isomerate; and (c) a carrier.
2. The topical skincare composition of claim 1, wherein the carrier is Aloe Barbadensis leaf juice.
3. The topical skincare composition of claim 1, wherein the percentage of Saccharide Isomerate in the composition is about 10% weight by weight.
4. The topical skincare composition of claim 1, wherein the composition further includes D panthenol.
5. The topical skincare composition of claim 1, wherein the composition further includes Water, Disodium Phosphate, Acetyl Hexapeptide-8, Sodium Phosphate, Capryloyl Glycol.
6. The topical skincare composition of claim 1, wherein the composition further includes a combination of water, propanediol and Tephrosia Purpurea seed extract.
7. The topical skincare composition of claim 1, wherein the composition further includes a fragrance.
8. The topical skincare composition of claim 1, wherein the composition further includes Xanthan gum.
9. The topical skincare composition of claim 1, wherein the composition further includes Propanediol.
10. The topical skincare composition of claim 1, wherein the composition further includes Brachychiton acerifolius extract.
11. The topical skincare composition of claim 1, wherein the composition further includes Tasmannia lanceolata leaf extract.
12. The topical skincare composition of claim 1, wherein the composition further includes Calitris Glaucophylla leaf extract.
13. The topical skincare composition of claim 1, wherein the composition further includes Tasmannia lanceolata berry extract.
14. The topical skincare composition of claim 1, wherein the composition further includes Davidsonia jerseyana extract
15. The topical skincare composition of claim 1, wherein the composition further includes Arnica Montana extract.
16. The topical skincare composition of claim 1, wherein the composition further includes Kunzea Pomifera extract.
17. The topical skincare composition of claim 1, wherein the composition further includes Anigozanthos Flavidus extract.
18. The topical skincare composition of claim 1, wherein the composition further includes Narcissus Tazetta bulb extract.
19. The topical skincare composition of claim 1, wherein the composition further includes Schisandra Chinensis fruit extract.
20. The topical skincare composition of claim 1, wherein the composition further includes Magnolia Grandiflora oil.
AU2021103389A 2020-06-19 2021-06-16 A Skincare Serum Active AU2021103389A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2020902044 2020-06-19
AU2020902044A AU2020902044A0 (en) 2020-06-19 A Skincare Serum

Publications (1)

Publication Number Publication Date
AU2021103389A4 true AU2021103389A4 (en) 2021-08-12

Family

ID=77195617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021103389A Active AU2021103389A4 (en) 2020-06-19 2021-06-16 A Skincare Serum

Country Status (1)

Country Link
AU (1) AU2021103389A4 (en)

Similar Documents

Publication Publication Date Title
RU2562140C2 (en) Composition and method of treating signs of skin aging
AU5313000A (en) Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
WO2001085156A1 (en) Dermal compositions containing coenzyme q as the active ingredient
CN101035507B (en) Cosmetic compositions comprising specific cyclohexanmono-, -di- or -triols or cyclohexyl methan- or -ethan- or -propoanols
JP5329830B2 (en) SCF secretion inhibitor and sebum secretion inhibitor
CN116634996A (en) Composition for treating hair, scalp and skin
KR20200066420A (en) Cosmetic composition for skin antiaging containing sodium dna and astazanthine
JPH08176005A (en) Living body-aging preventive and composition for skin
KR20170038581A (en) Composition containing aha, urea, and niacinamide for softening and whitening stratum corneum
AU2021103389A4 (en) A Skincare Serum
JP2007332078A (en) Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)
US8334001B2 (en) Composition comprising mucilaginous polysaccharides derived from aloe barbadensis and method for obtaining same and use thereof
CH700735B1 (en) Biologically active complex, useful e.g. as a cosmetic anti-aging composition, comprises a combination of amino acids, a soy protein hydrolyzate, teprenone and fine Myrtus communis plant extract
US20200085959A1 (en) Cannabinoid and Terpene-Infused Topical Cream
JP2009001575A (en) Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)
US10537507B2 (en) All-in-one skin brightening formulations specifically for pregnant subjects
DE102006040450B3 (en) Use of a composition for skin treatment after X-irradiation
KR20090028275A (en) Cosmetic materials for anti-aging and winkle reducing effects having essential oil complex as its principal ingredient, and the manufacturing method thereof
KR20150057390A (en) Compositions containing an mixed components of dehydro-abietic acid and trans-communic acid for anti-aging
IT201800009679A1 (en) METHOD FOR CHANGING THE ODOR OF OZONIZED OIL
KR20130057634A (en) Method of stabilizing egcg and composition for whitening skin containing egcg
KR102233710B1 (en) Cosmetic composition containing salt and manufacturing method thereof
AU2021104419A4 (en) Polyherbal Gel formulation for growth of Hair Follicle
CN114432193A (en) Composition for resisting skin aging and preparation method thereof
EP4268799A1 (en) Skin treatment composition containing cannabinoids

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)